Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
Read the press release here. You may not have heard of astrocytes before, but your body is full of them: they make up more than...
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
One of the great advantages of stem cells is that they can be used to make personalized models of disease — they let us study exactly...
The Context: Alzheimer’s-affected brains do not make new neurons out of neural stem cells as efficiently as healthy brains, and this is an early sign of...
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
NYSCF Research Institute scientists in collaboration with researchers at the Icahn School of Medicine at Mount Sinai refined a technique to turn skin cells from patients...
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden and his team at MIT Media Lab published their latest work on an exciting new, noninvasive approach to treating...
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
Bringing treatments out of laboratories and into clinics remains a major obstacle for healthcare. Mice and other common lab animals cannot reliably predict human responses to...
Dr. Gary Gibson, Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at Weill Cornell Medical College, joined NYSCF as a visiting scientist...
Dr. Scott Noggle, NYSCF Vice President for Stem Cell Research, presented NYSCF’s latest Alzheimer’s disease research as the keynote speaker at the Alzheimer’s Disease Resource Center’s...
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
Dr. Scott Noggle, Director of the NYSCF Laboratory and NYSCF – Charles Evans Senior Research Fellow for Alzheimer’s Disease, presented the latest in Alzheimer’s research at the...
NYSCF scientists, in collaboration with scientists from the Icahn School of Medicine at Mount Sinai, successfully created and used a stem cell model of familial Alzheimer’s...
